Nectar Lifesciences Limited
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nectar Lifesciences Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1% to $16,840,860,000. Profit margin reached 0%. Total operating expenses were $932,700,000.
Profit Margin
| 2010 | 8.85B | 922.89M | 10.42% |
|---|---|---|---|
| 2011 | 10.55B | 1.03B | 9.77% |
| 2012 | 13.03B | 732.16M | 5.62% |
| 2015 | 16.42B | 662.64M | 4.03% |
| 2016 | 16.75B | 591.94M | 3.53% |
| 2018 | 18.76B | 522.72M | 2.79% |
| 2019 | 27.82B | 476M | 1.71% |
| 2021 | 15.43B | -732.64M | -4.75% |
| 2022 | 16.68B | 250.47M | 1.5% |
| 2024 | 16.84B | 49.95M | 0.3% |
NECLIFE.NS Income Statement (2010 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 16.84B | 16.68B | 15.43B | 27.82B | 18.76B | 16.75B | 16.42B | 13.03B | 10.55B | 8.85B |
Cost of revenue | 12.02B | 13.69B | 12.85B | 23.70B | 15.11B | 12.77B | 12.56B | 9.89B | 7.54B | 93.95M |
Gross profit | 4.81B | 2.99B | 2.57B | 4.12B | 3.65B | 3.98B | 3.86B | 3.14B | 3.01B | 8.76B |
Operating exp. | ||||||||||
Research and development | 0 | 30.7M | 24.35M | 0 | 60.09M | 360.22M | 0 | 0 | 0 | 0 |
Selling and marketing | 389.91M | 480.27M | 507.87M | 456.59M | 287.17M | 343.22M | 352.53M | 188.6M | 210.75M | 224.66M |
Total operating expenses | 932.7M | 1.97B | 1.95B | 2.10B | 1.92B | 2.01B | 1.95B | 1.38B | 1.07B | 7.11B |
Operating income | 3.89B | 1.01B | 499.91M | 2.01B | 1.72B | 1.96B | 1.90B | 1.75B | 1.93B | 1.64B |
Other income (expenses), net | -3.70B | -675.16M | -1.35B | -1.42B | -1.09B | -1.17B | -1.05B | -901.01M | 731.39M | 494.26M |
Income before tax | 182.69M | 340.8M | -847.67M | 588.2M | 626.83M | 724.9M | 847.54M | 854.32M | 1.20B | 1.15B |
Income tax expense | 132.74M | 90.34M | -115.04M | 112.2M | 104.11M | 132.96M | 184.9M | 122.16M | 173.47M | 230.1M |
Net income | 49.95M | 250.47M | -732.64M | 476M | 522.72M | 591.94M | 662.64M | 732.16M | 1.03B | 922.89M |
Earnings per share | ||||||||||
Basic EPS | 0.22 | 1.12 | -3.27 | 2.12 | 2.33 | 2.42 | 2.95 | 3.27 | 4.65 | 5.83 |
Diluted EPS | 0.22 | 1.12 | -3.27 | 2.12 | 2.33 | 2.42 | 2.95 | 3.27 | 4.65 | 4.29 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |